Cargando…

Effects Of The COVID-19 Pandemic On A Group Of Patients With Pathogenic Variant of Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA-4) in a Tertiary Center in Florida

Detalles Bibliográficos
Autores principales:	Timothy, Priyanka, Illes, Peter, Ujhazi, Boglarka, Gordon, Sumai, Nagy, Bence, Alas, Eugenia, Sullivan, Shannon, Miranda, Mary Ann, Duff, Carla, Farmer, Jocelyn, Sriaroon, Panida, Szymanski, Ann Marie, Csomos, Krisztian, Westermann-Clark, Emma, Dasso, Joseph, Walter, Jolan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804520/ http://dx.doi.org/10.1016/j.jaci.2021.12.125

Ejemplares similares

The Humoral Immune Response To SARS-CoV-2 Infection And/or Immunization in Immunocompromised Versus Immunocompetent Individuals
por: Illes, Peter, et al.
Publicado: (2022)

Anti-interferon-alpha autoantibodies in patients with inborn errors of Immunity and rheumatic diseases before and during the COVID-19 pandemic
por: Dasso, Joseph, et al.
Publicado: (2023)

Characteristics and Clinical Implications of Anti-IFN-α cytokine antibodies in partial Recombinase Activating Gene Deficiency patients before and during the COVID-19 Pandemic
por: Gordon, Sumai, et al.
Publicado: (2023)

COVID-19-Related Encephalitis in a Child with PIK3CD Defect
por: Potts, David, et al.
Publicado: (2023)

Familial Immune Thrombocytopenia Associated With a Novel Variant in IKZF1
por: Sriaroon, Panida, et al.
Publicado: (2019)

Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
por: Mammadova, Jamila, et al.
Publicado: (2022)

Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
por: Mammadova, Jamila, et al.
Publicado: (2022)

Clinical Characteristics of SARS-CoV2 Infected and Exposed Patients at a Tertiary Care Allergy/Immunology Program in Florida
por: Miranda, Mary Ann, et al.
Publicado: (2021)

Lineage Reconstruction of In Vitro Identified Antigen-Specific Autoreactive B Cells from Adaptive Immune Receptor Repertoires
por: Blazso, Peter, et al.
Publicado: (2022)

Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency
por: Dorna, Mayra B., et al.
Publicado: (2019)

Hyaluronidase-Facilitated High-Dose Subcutaneous IgG Effectively Controls Parvovirus B19 Infection in a Pediatric Cardiac Transplant Patient With Severe T-Cell Lymphopenia
por: Cruz, Rachel J, et al.
Publicado: (2020)

Two Unique Cases of X-linked SCID: A Diagnostic Challenge in the Era of Newborn Screening
por: Purswani, Pooja, et al.
Publicado: (2019)

Arthritis in Two Patients With Partial Recombination Activating Gene Deficiency
por: Wu, Kevin Y., et al.
Publicado: (2019)

Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the PIK3CD Gene
por: Wang, Wenjie, et al.
Publicado: (2022)

Asymptomatic Infant With Atypical SCID and Novel Hypomorphic RAG Variant Identified by Newborn Screening: A Diagnostic and Treatment Dilemma
por: Chitty-Lopez, Maria, et al.
Publicado: (2020)

Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection
por: Bindernagel, Constance, et al.
Publicado: (2023)

Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort
por: Westermann-Clark, Emma, et al.
Publicado: (2021)

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
por: Gerdes, Lisa Ann, et al.
Publicado: (2016)

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms
por: Berry, Andrew, et al.
Publicado: (2008)

CTLA-4: From conflict to clinic
por: Bashyam, Hema
Publicado: (2007)

The role of CTLA-4 in immune regulation
por: Verhagen, Johan, et al.
Publicado: (2008)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CTLA-4 Insufficiency due to a Novel CTLA-4 Deletion, Identified through Copy Number Variation Analysis
por: Olfe, Lisa, et al.
Publicado: (2022)

Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
por: Rojas‑Restrepo, Jessica, et al.
Publicado: (2023)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Liu, Hsin-Yu, et al.
Publicado: (2021)

CTLA4 polymorphism and primary Sjögren's syndrome
por: Lester, Susan, et al.
Publicado: (2007)

CTLA-4 based therapy (MDX-010)
por: Korman, A
Publicado: (2003)

CTLA-4 and Autoimmunity: New Twists in the Tale
por: Walker, Lucy S.K.
Publicado: (2015)

Effects of CTLA4-Ig on human monocytes
por: Tono, Toshihiro, et al.
Publicado: (2017)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2021)

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
por: Hoffmann, Friederike, et al.
Publicado: (2023)

Blood PD-1(+)TFh and CTLA-4(+)CD4(+) T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis
por: Aldridge, Jonathan, et al.
Publicado: (2021)

Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
por: Egg, David, et al.
Publicado: (2018)

(64)Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues
por: Higashikawa, Kei, et al.
Publicado: (2014)

Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice
por: Du, Xuexiang, et al.
Publicado: (2018)

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma
por: Khanolkar, Rahul C., et al.
Publicado: (2022)

CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
por: Rochmah, Nur, et al.
Publicado: (2022)

CTLA-4: a negative regulator of autoimmune disease
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_152v82cm2rt8vsv6v38qdoskp0